Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

12th International Society of Neuroimmunology Congress
Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
SMC Says Yes to Aubagio® (teriflunomide), a New Once Daily First-line Oral Treatment Available for People with an Active Relapsing Remitting Form of MS
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
BIIB033 single ascending dose study in healthy volunteer subjects
Parenteral Dilantin®
FOCIS 2014: Spotlight on Translational Immunology
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
ACTRIMS-ECTRIMS 2014 -- Day 1, afternoon
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Remyelination in experimental models of toxin-induced demyelination.
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
2015 Annual Meeting of the Consortium of the Multiple Sclerosis Centers
ECTRIMS 2015
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
MS Research Roundup: January 31, 2014
MS Research Roundup: January 29, 2014
Episode 56 with Dr. Gavin Giovannoni, on early phase 3 results of ocrelizumab, the first experimental drug to show some benefit in a progressive form of multiple sclerosis in a major trial
Transfer of interferon β-1a into human breastmilk.

Pages